U.S. Markets closed

Zoetis Inc. (ZTS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
60.90-0.60 (-0.98%)
At close: 4:02PM EDT

60.70 -0.20 (-0.33%)
After hours: 6:53PM EDT

People also watch

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States

IndustryDrugs - Generic
Full Time Employees9,000

Key Executives

Mr. Juan Ramón AlaixChief Exec. Officer and Director3.17MN/A66
Mr. Glenn C. DavidChief Financial Officer and Exec. VP1.08M370.4kN/A
Dr. Catherine A. KnuppExec. VP and Pres of R&D1.09MN/A56
Mr. Clinton A. Lewis Jr.Exec. VP and Pres of International Operations2.17MN/A50
Ms. Kristin C. PeckExec. VP and Pres of US Operations1.32MN/A46
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the United States and internationally. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. The company also provides medicated feed additives that offer medicines to livestock; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products. In addition, it offers other product categories comprising nutritionals and agribusiness services, as well as products and services in complementary areas consisting of biodevices, diagnostics, and genetics. The company markets its products to veterinarians and livestock producers through its sales representatives, and technical and veterinary operations specialists. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Corporate Governance

Zoetis Inc.’s ISS Governance QualityScore as of August 1, 2017 is 8. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 9; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.